The Group's principal activity is designing, developing, manufacturing and marketing retinal imaging devices. The product is used as a tool for the screening and diagnosis of eye problems, such as retinal detachment, glaucoma, cataracts, retinal holes/retinal tears and age-related macular degeneration. It can also indicate evidence of non-eye diseases, such as diabetes, hypertension and certain cancers. It also manufactures and installs retinal examination equipment at healthcare professional sites. The Group's core product is the optomap Retinal Exam, which is used in primary level eye and healthcare for the screening of eye and non-eye diseases and disorders. The Group's other products are optomap plus Medical Retinal Exam, optomap fa Medical Procedure, V2 Vantage and ResMax. Operations are carried out in North America and Europe.
Alacra Alerts:
Receive alerts on the latest reports on Optos PLC
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
